nejm tirzepatide osa This study by Malhotra et al., published in the investigated the effects of (Zepbound), a GIP and GLP-1 agonist, on obstructive sleep apnea (OSA) and related outcomes in adults with FDA Approves First Sleep Apnea

Semaglutide monotherapy similarly produces measurable outcomes in non-obese populations, though typically at lower absolute weight loss magnitude compared to tirzepatide's dual mechanism

Abrupt discontinuation of tirzepatide may provoke rebound hunger and rapid weight regain (food noise)transition should be structured and supported

Tim Ferriss talks with Paul Stamets, an American mycologist and Fungi fanatic, about just how powerful mushrooms can be to your health: 4

From that, the PRAC has concluded that the data does not support a causal association between the drugs and thyroid cancer and sees no need to update the product information at this time